Korecyte Bio
PrivateLast Round
Seed
May 26, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Korecyte Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in May 2026.
Korecyte Bio is a biotechnology company that develops next-generation CAR-T cellular immunotherapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Korecyte Bio Comparables
Compare Korecyte Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leucid Bio | 85% | |
| CREATE Medicines | 71% | |
| AstraZeneca | 71% |
For institutional investors. Book with your work email.
Korecyte Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 26, 2026 | ||||
| Grant | Aug 27, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Korecyte Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cell and Gene Therapy Catapult | Seed |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 672% MoM, reaching 1.2K.
- Aug 27, 2024
Received grant funding from Innovate UK.
For institutional investors. Book with your work email.
Korecyte Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Korecyte Bio's valuation, stock price, and market status.
Is Korecyte Bio a public or private company?
Korecyte Bio is a private company.
What is the current stock price of Korecyte Bio?
Korecyte Bio is a private company, so its shares have no public market price. Caplight tracks Korecyte Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Korecyte Bio worth (valuation)?
Valuation information for Korecyte Bio is not publicly available.
Can I buy Korecyte Bio stock?
Korecyte Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Korecyte Bio's last funding round?
Korecyte Bio's most recent funding round was Seed on May 26, 2026.
Who are the main investors in Korecyte Bio?
Key investors in Korecyte Bio include Cell and Gene Therapy Catapult, Innovate UK.
Will Korecyte Bio IPO soon?
No public IPO plans have been announced for Korecyte Bio.
How can I track Korecyte Bio secondary market activity?
Caplight tracks bids, offers, and trades in Korecyte Bio's shares on secondary markets.